Señales en vivo de BICO.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 11:29):

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation...

Stats
Volumen de hoy	110 037
Volumen promedio	327 951
Capitalización de mercado	3.15B
EPS	SEK0 ( 2024-02-19 )
Próxima fecha de ganancias	( SEK-0.710 ) 2024-05-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.900
ATR14	SEK0.151 (0.33%)

Volumen Correlación

Largo: -0.15 (neutral)

Corto: -0.97 (very strong negative)

Signal:(56.555) Neutral

BICO Group AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BICO Group AB (publ) Correlación - Moneda/Commodity

-0.23
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.36
( neutral )

-0.24
( neutral )

0.40
( neutral )

BICO Group AB (publ) Finanzas

Annual	2022
Ingresos:	SEK2.24B
Beneficio Bruto:	SEK1.83B (81.74 %)
EPS:	SEK-12.99

FY	2022
Ingresos:	SEK2.24B
Beneficio Bruto:	SEK1.83B (81.74 %)
EPS:	SEK-12.99

FY	2021
Ingresos:	SEK1.26B
Beneficio Bruto:	SEK1.00B (79.72 %)
EPS:	SEK-3.97

FY	2020
Ingresos:	SEK176.79M
Beneficio Bruto:	SEK163.62M (92.55 %)
EPS:	SEK-1.500

Financial Reports:

No articles found.

BICO Group AB (publ)

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.